Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort

Marie Hairing Enemark; Jonas Klejs Hemmingsen; Maja Dam Andersen; Trine Engelbrecht Hybel; Mads Emil Bjørn; Pär Lars Josefsson; Lars Møller Pedersen; Maja Bech Juul; Robert Schou Pedersen; Michael Thorsgaard; Ida Blok Sillesen; Trine Lindhardt Plesner; Stephen Jacques Hamilton-Dutoit; Paw Jensen; Charlotte Madsen; Maja Ludvigsen

doi:10.1038/s41408-024-01150-3

Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort

Marie Hairing Enemark^*, Jonas Klejs Hemmingsen, Maja Dam Andersen, Trine Engelbrecht Hybel, Mads Emil Bjørn, Pär Lars Josefsson, Lars Møller Pedersen, Maja Bech Juul, Robert Schou Pedersen, Michael Thorsgaard, Ida Blok Sillesen, Trine Lindhardt Plesner, Stephen Jacques Hamilton-Dutoit, Paw Jensen, Charlotte Madsen, Maja Ludvigsen^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Letter › peer review

4 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	167
Tidsskrift	Blood Cancer Journal
Vol/bind	14
Antal sider	4
DOI	https://doi.org/10.1038/s41408-024-01150-3
Status	Udgivet - 30 sep. 2024

Adgang til dokumentet

10.1038/s41408-024-01150-3Licens: CC BY-NC-ND 4.0

Enemark et al. (2024). Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohortForlagets udgivne version, 1,17 MBLicens: CC BY-NC-ND 4.0

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

Link to publication in Scopus

Citationsformater

Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B., Pedersen, R. S., Thorsgaard, M., Sillesen, I. B., Plesner, T. L., Hamilton-Dutoit, S. J., Jensen, P., Madsen, C., & Ludvigsen, M. (2024). Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort. Blood Cancer Journal, 14, Artikel 167. https://doi.org/10.1038/s41408-024-01150-3

@article{d9c6593cb323473ea8fe40fd390682b8,

title = "Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort",

author = "Enemark, {Marie Hairing} and Hemmingsen, {Jonas Klejs} and Andersen, {Maja Dam} and Hybel, {Trine Engelbrecht} and Bj{\o}rn, {Mads Emil} and Josefsson, {P{\"a}r Lars} and Pedersen, {Lars M{\o}ller} and Juul, {Maja Bech} and Pedersen, {Robert Schou} and Michael Thorsgaard and Sillesen, {Ida Blok} and Plesner, {Trine Lindhardt} and Hamilton-Dutoit, {Stephen Jacques} and Paw Jensen and Charlotte Madsen and Maja Ludvigsen",

year = "2024",

month = sep,

day = "30",

doi = "10.1038/s41408-024-01150-3",

language = "English",

volume = "14",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

}

Enemark, MH, Hemmingsen, JK, Andersen, MD, Hybel, TE, Bjørn, ME, Josefsson, PL, Pedersen, LM, Juul, MB, Pedersen, RS, Thorsgaard, M, Sillesen, IB, Plesner, TL, Hamilton-Dutoit, SJ, Jensen, P, Madsen, C & Ludvigsen, M 2024, 'Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort', Blood Cancer Journal, bind 14, 167. https://doi.org/10.1038/s41408-024-01150-3

Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort. / Enemark, Marie Hairing; Hemmingsen, Jonas Klejs; Andersen, Maja Dam et al.
I: Blood Cancer Journal, Bind 14, 167, 30.09.2024.

Publikation: Bidrag til tidsskrift › Letter › peer review

TY - JOUR

T1 - Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort

AU - Enemark, Marie Hairing

AU - Hemmingsen, Jonas Klejs

AU - Andersen, Maja Dam

AU - Hybel, Trine Engelbrecht

AU - Bjørn, Mads Emil

AU - Josefsson, Pär Lars

AU - Pedersen, Lars Møller

AU - Juul, Maja Bech

AU - Pedersen, Robert Schou

AU - Thorsgaard, Michael

AU - Sillesen, Ida Blok

AU - Plesner, Trine Lindhardt

AU - Hamilton-Dutoit, Stephen Jacques

AU - Jensen, Paw

AU - Madsen, Charlotte

AU - Ludvigsen, Maja

PY - 2024/9/30

Y1 - 2024/9/30

UR - http://www.scopus.com/inward/record.url?scp=85205446716&partnerID=8YFLogxK

U2 - 10.1038/s41408-024-01150-3

DO - 10.1038/s41408-024-01150-3

M3 - Letter

C2 - 39349431

AN - SCOPUS:85205446716

SN - 2044-5385

VL - 14

JO - Blood Cancer Journal

JF - Blood Cancer Journal

M1 - 167

ER -